BairdKSCrossanJFRalstonSH. Abnormal growth factor and cytokine expression in Dupuytren’s contracture. J Clin Pathol. 1993;46:425-428.
2.
BeaudreuilJLermusiauxJLTeyssedouJP. Multi-needle aponeurotomy for advanced Dupuytren’s disease: preliminary results of safety and efficacy (MNA 1 study). Joint Bone Spine. 2011;78:625-628.
3.
BeckmannJKalteisTBaerWGrifkaJLerchK. Plantar fibromatosis: therapy by total plantarfasciectomy. Zentralbl Chir. 2004;129:53-57.
4.
BediDGDavidsonDM. Plantar fibromatosis: most common sonographic appearance and variations. J Clin Ultrasound. 2001;29:499-505.
5.
BunkerTDAnthonyPP. The pathology of frozen shoulder: a Dupuytren-like disease. J Bone Joint Surg Br. 1995;77:677-683.
6.
ClassenDAHurstLN. Plantar fibromatosis and bilateral flexion contractures: a review of the literature. Ann Plast Surg. 1992;28:475-478.
7.
de BreeEZoetmulderFAKeusRBPeterseHLvan CoevordenF. Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg. 2004;187:33-38.
8.
de PalmaLSantucciAGiganteADi GiulioACarloniS. Plantar fibromatosis: an immunohistochemical and ultrastructural study. Foot Ankle Int. 1999;20:253-257.
9.
DonatoRRMorrisonWA. Dupuytren’s disease in the feet causing flexion contractures in the toes. J Hand Surg Br. 1996;21:364-366.
10.
DürrHRKrödelATrouillierHLienemannARefiorHJ. Fibromatosis of the plantar fascia: diagnosis and indications for surgical treatment. Foot Ankle Int. 1999;2013-2017.
11.
ElhaddTAGhoshSMalikMICollierA. Plantar fibromatosis and Dupuytren’s disease: an association to remember in patients with diabetes. Diabet Med. 2007;24:1305.
12.
FarsettiPTudiscoCCateriniRBellocciM. Ledderhose’s disease: case study with histologic and ultrastructural analysis. Ital J Orthop Traumatol. 1992;18:129-133.
GilpinDColemanSHallSHoustonAKarraschJJonesN. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am. 2010;35:2027-2038.
GriffithJFWongTYWongSMWongMWMetreweliC. Sonography of plantar fibromatosis. AJR Am J Roentgenol. 2002;179:1167-1172.
18.
HaedickeGJSturimHS. Plantar fibromatosis: an isolated disease. Plast Reconstr Surg. 1989;83:296-300.
19.
HeydRDornAPHerkströterMRödelCMüller-SchimpfleMFraunholzI. Radiation therapy for early stages of morbus Ledderhose. Strahlenther Onkol. 2010;186:24-29.
20.
HolzerLAHolzerG. Collagenase clostridium histolyticum in the management of Dupuytren’s contracture. Handchir Mikrochir Plast Chir. 2011;43:269-274.
21.
JohnstonFECollisSPeckhamNHRothsteinAR. Plantar fibromatosis: literature review and a unique case report. J Foot Surg. 1992;31:400-406.
22.
KetchumLDDonahueTK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg Am. 2000;25:1157-1162.
23.
KnoblochKKuehnMVogtPM. Focused extracorporeal shockwave therapy in Dupuytren’s disease—a hypothesis. Med Hypotheses. 2011;76:635-637.
24.
KnoblochKVogtPM. High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (Ledderhose’s disease). BMC Res Notes. 2012;5:542.
25.
KuhnMAWangXPayneWGKoFRobsonMC. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren’s affected palmar fascia. J Surg Res. 2002;103:146-152.
26.
LedderhoseG. Zur Pathologie der Aponeurose des Fusses und der Hand. Arch Klin Chir. 1897;55:694-712.
27.
LeeTHWapnerKLHechtPJ. Plantar fibromatosis. J Bone Joint Surg Am. 1993;75:1080-1084.
28.
MeekRMMcLellanSReillyJCrossanJF. The effect of steroids on Dupuytren’s disease: role of programmed cell death. J Hand Surg Br. 2002;27:270-273.
29.
MurellGACHuestonJT. Aetiology of Dupuytren’s contracture. Aust NZ J Surg. 1990;60:247-252.
30.
PalettaFX. Dupuytren’s contracture. Am Fam Physician. 1981;23:85-90.
31.
PalmieriAImbimboCLongoN. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol. 2009;56:363-369.
32.
PasternackWADavisonGA. Plantar fibromatosis: staging by magnetic resonance imaging. J Foot Ankle Surg. 1993;32:390-396.
33.
PentlandAPAndersonTF. Plantar fibromatosis responds to intralesional steroids. J Am Acad Dermatol. 1985;12:212-214.
34.
SammarcoGJMangonePG. Classification and treatment of plantar fibromatosis. Foot Ankle Int. 2000;21:563-569.
35.
SeegenschmiedtMHAttassiM. Radiation therapy for morbus Ledderhose—indication and clinical results. Strahlenther Onkol. 2003;179:847-853.
36.
TomasekJJVaughanMBHaaksmaCJ. Cellular structure and biology of Dupuytren’s disease. Hand Clin. 1999;15:21-34.
37.
TripoliMCordovaAMoschellaF. Dupuytren’s contracture as result of prolonged administration of phenobarbital. Eur Rev Med Pharmacol Sci. 2011;15:299-302.
38.
van der VeerWMHamburgSMde GastANiessenFB. Recurrence of plantar fibromatosis after plantar fasciectomy: single-center long-term results. Plast Reconstr Surg. 2008;122:486-491.
39.
ZamoraRLHeightsRKraemerBAErlichHPGronerJP. Presence of growth factors in palmar and plantar fibromatoses. J Hand Surg Am. 1994;19:435-441.
